136 related articles for article (PubMed ID: 30149075)
1. New azole derivatives of [17(20)E]-21-norpregnene: Synthesis and inhibition of prostate carcinoma cell growth.
Dalidovich TS; Hurski AL; Morozevich GE; Latysheva AS; Sushko TA; Strushkevich NV; Gilep AA; Misharin AY; Zhabinskii VN; Khripach VA
Steroids; 2019 Jul; 147():10-18. PubMed ID: 30149075
[TBL] [Abstract][Full Text] [Related]
2. Comparison of [17(20)E]-21-Norpregnene oxazolinyl and benzoxazolyl derivatives as inhibitors of CYP17A1 activity and prostate carcinoma cells growth.
Zolottsev VA; Tkachev YV; Latysheva AS; Kostin VA; Novikov RA; Timofeev VP; Morozevich GE; Kuzikov AV; Shumyantseva VV; Misharin AY
Steroids; 2018 Jan; 129():24-34. PubMed ID: 29183745
[TBL] [Abstract][Full Text] [Related]
3. Design and evaluation of novel oxadiazole derivatives as potential prostate cancer agents.
Mochona B; Qi X; Euynni S; Sikazwi D; Mateeva N; Soliman KF
Bioorg Med Chem Lett; 2016 Jun; 26(12):2847-2851. PubMed ID: 27156770
[TBL] [Abstract][Full Text] [Related]
4. Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model.
Handratta VD; Vasaitis TS; Njar VC; Gediya LK; Kataria R; Chopra P; Newman D; Farquhar R; Guo Z; Qiu Y; Brodie AM
J Med Chem; 2005 Apr; 48(8):2972-84. PubMed ID: 15828836
[TBL] [Abstract][Full Text] [Related]
5. Oxazolinyl derivatives of [17(20)E]-21-norpregnene differing in the structure of A and B rings. Facile synthesis and inhibition of CYP17A1 catalytic activity.
Kostin VA; Zolottsev VA; Kuzikov AV; Masamrekh RA; Shumyantseva VV; Veselovsky AV; Stulov SV; Novikov RA; Timofeev VP; Misharin AY
Steroids; 2016 Nov; 115():114-122. PubMed ID: 27505042
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors.
Zhang YB; Wang XL; Liu W; Yang YS; Tang JF; Zhu HL
Bioorg Med Chem; 2012 Nov; 20(21):6356-65. PubMed ID: 23018096
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of benzosuberone embedded with 1,3,4-oxadiazole, 1,3,4-thiadiazole and 1,2,4-triazole moieties as new potential anti proliferative agents.
Yadagiri B; Gurrala S; Bantu R; Nagarapu L; Polepalli S; Srujana G; Jain N
Bioorg Med Chem Lett; 2015; 25(10):2220-4. PubMed ID: 25827522
[TBL] [Abstract][Full Text] [Related]
8. Oxazolinyl derivatives of androst-16-ene as inhibitors of CYP17A1 activity and prostate carcinoma cells proliferation: Effects of substituents in oxazolinyl moiety.
Latysheva AS; Zolottsev VA; Veselovsky AV; Scherbakov KA; Morozevich GE; Zhdanov DD; Novikov RA; Misharin AY
J Steroid Biochem Mol Biol; 2023 Jun; 230():106280. PubMed ID: 36870373
[TBL] [Abstract][Full Text] [Related]
9. Azoles and bis-azoles: synthesis and biological evaluation as antimicrobial and anti-cancer agents.
Kheder NA; Riyadh SM; Asiry AM
Chem Pharm Bull (Tokyo); 2013; 61(5):504-10. PubMed ID: 23649193
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of novel hydrazone and azole functionalized pyrazolo[3,4-b]pyridine derivatives as promising anticancer agents.
Nagender P; Naresh Kumar R; Malla Reddy G; Krishna Swaroop D; Poornachandra Y; Ganesh Kumar C; Narsaiah B
Bioorg Med Chem Lett; 2016 Sep; 26(18):4427-4432. PubMed ID: 27528432
[TBL] [Abstract][Full Text] [Related]
11. 1,3,5-Triazine-azole Hybrids and their Anticancer Activity.
Guo H; Diao QP
Curr Top Med Chem; 2020; 20(16):1481-1492. PubMed ID: 32156236
[TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis, and Biological Evaluation of New Azole Derivatives as Potent Aromatase Inhibitors with Potential Effects against Breast Cancer.
Kalalinia F; Jouya M; Komachali AK; Aboutourabzadeh SM; Karimi G; Behravan J; Abnous K; Etemad L; Kamali H; Hadizadeh F
Anticancer Agents Med Chem; 2018; 18(7):1016-1024. PubMed ID: 29336269
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of novel arylpiperazine derivatives on human prostate cancer cell lines.
Chen H; Xu F; Liang X; Xu BB; Yang ZL; He XL; Huang BY; Yuan M
Bioorg Med Chem Lett; 2015 Jan; 25(2):285-7. PubMed ID: 25488843
[TBL] [Abstract][Full Text] [Related]
14. New steroidal oxazolines, benzoxazoles and benzimidazoles related to abiraterone and galeterone.
Latysheva AS; Zolottsev VA; Veselovsky AV; Scherbakov KA; Morozevich GE; Pokrovsky VS; Novikov RA; Timofeev VP; Tkachev YV; Misharin AY
Steroids; 2020 Jan; 153():108534. PubMed ID: 31678134
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis and Anticancer Activity of New Thiazole-Tetrazole or Triazole Hybrid Glycosides Targeting CDK-2 via Structure-Based Virtual Screening.
Kassem AF; Abbas EMH; El-Kady DS; Awad HM; El-Sayed WA
Mini Rev Med Chem; 2019; 19(11):933-948. PubMed ID: 30599108
[TBL] [Abstract][Full Text] [Related]
16. Antiproliferative, proapoptotic, and tumor-suppressing effects of the novel anticancer agent alsevirone in prostate cancer cells and xenografts.
Khan II; Karshieva SS; Sokolova DV; Spirina TS; Zolottsev VA; Latysheva AS; Anisimova NY; Komarova MV; Yakunina MN; Nitetskaya TA; Misharin AY; Pokrovsky VS
Arch Pharm (Weinheim); 2022 Jan; 355(1):e2100316. PubMed ID: 34668210
[TBL] [Abstract][Full Text] [Related]
17. Isatin-azole hybrids and their anticancer activities.
Hou Y; Shang C; Wang H; Yun J
Arch Pharm (Weinheim); 2020 Jan; 353(1):e1900272. PubMed ID: 31691360
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, Characterization, and Preliminary In Vitro Cytotoxic Evaluation of a Series of 2-Substituted Benzo [
Linares-Anaya O; Avila-Sorrosa A; Díaz-Cedillo F; Gil-Ruiz LÁ; Correa-Basurto J; Salazar-Mendoza D; Orjuela AL; Alí-Torres J; Ramírez-Apan MT; Morales-Morales D
Molecules; 2021 May; 26(9):. PubMed ID: 34066820
[TBL] [Abstract][Full Text] [Related]
19. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of 17β-N-arylcarbamoylandrost-4-en-3-one derivatives and their anti-proliferative effect on human androgen-sensitive LNCaP cell line.
Cortés-Benítez F; Cabeza M; Ramírez-Apan MT; Alvarez-Manrique B; Bratoeff E
Eur J Med Chem; 2016 Oct; 121():737-746. PubMed ID: 27423983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
